Duncan had been receiving the experimental drug brincidofovir since Saturday. The latest update on his condition, released yesterday afternoon by the hospital, was that he was on a ventilator and had been receiving kidney dialysis.
A statement from the hospital about the news of Duncan’s passing reads:
It is with profound sadness and heartfelt disappointment that we must inform you of the death of Thomas Eric Duncan this morning at 7:51 am. Mr. Duncan succumbed to an insidious disease, Ebola. He fought courageously in this battle. Our professionals, the doctors and nurses in the unit, as well as the entire Texas Health Presbyterian Hospital Dallas community, are also grieving his passing. We have offered the family our support and condolences at this difficult time.